Covaris truXTRAC® extraction combined with PacBio's Kinnex™ library preparation generated high-yield, high-quality HiFi data from archival FFPE tumor samples at ESHG 2026, detecting over 11,000 structural variants per sample and 60% phased into haplotypes.
Public source
Publisher name
Public post
FFPE tissue has long been difficult territory for HiFi long-read sequencing, until now. Deborah Moine from PacBio presented new work at ESHG 2026 showing how Covaris tru…
Company
Covaris
- Industry
- Biotechnology Research
- Location
- Woburn, US
- Company size
- 51–200 employees
About Covaris
Covaris, a PerkinElmer Company, is a leader in sample preparation solutions across multiomics research and clinical applications. Powered by proprietary Adaptive Focused Acoustics® (AFA®) technology, our portfolio of advanced instruments, consumables, reagents, and kits for pre-analytical sample preparation deliver exceptional accuracy and reproducibility, enabling researchers to generate higher-quality data, develop novel assays, and drive breakthrough discoveries in life sciences. From academic labs to global biopharma organizations, Covaris is trusted by scientists who demand precision at every step of the analytical workflow. Learn more at www.covaris.com.
See moreLatest activity
Latest activity from Covaris
5 signals
Presence & Recognition
Covaris is hosting a webinar titled Expanding Access to Personalized Medicine with Cold Chain-Free, Remote Whole Blood Collection on September 9 at 2:00 PM EST.
Presence & Recognition
Covaris experts and collaborators will explore a comprehensive approach to sample prep at the HUPO World Congress on September 29.
Presence & Recognition
Covaris is attending a conference featuring experts from the University of Puerto Rico Medical Sciences Campus, University of Florida College of Medicine, and Covaris to explore the primary limitations of dried blood spots and saliva for NGS-based applications
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Oxford Nanopore Technologies
Oxford Nanopore Technologies published a study showing a single nanopore sequencing experiment with digital targeting provides SNVs, indels, copy number changes, gene fusions, and DNA methylation-based tumor classification with methylation correctly classifying 18 of 22 tumors after only 10 minutes of sequencing.
Research & Knowledge
PacBio
PacBio published a new paper describing Owl, a rust tool for analyzing microsatellite instability from PacBio HiFi sequencing data.
Research & Knowledge
Dovetail Genomics
Dovetail Genomics used the Dovetail FFPE Assay to characterize structural variants and resolve complex genomic rearrangements in tumor samples by researchers at the National Cancer Centre Singapore.
Research & Knowledge
Illumina
Illumina used StrataMap Spatial to investigate breast cancer tumor microenvironments and demonstrate unbiased whole-transcriptome spatial profiling.
Research & Knowledge
RevoluGen Ltd